author-photo

Carolyn Bodnar

AstraZeneca

6

Papers

39

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI

2018 Clinical Drug Investigation
Show All
- Source
- Cite
- Save
Citations (9)
Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer

2018 Journal of Medical Economics
Show All
- Source
- Cite
- Save
Citations (23)
P3.02b-080 Analysis of Patient-Reported Symptom Response with Osimertinib (AZD9291) Treatment for Advanced Non-Small-Cell Lung Cancer: Topic: EGFR Clinical

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P3.02b-021 Comparing T790M Identification across Testing Strategies in Advanced EGFR NSCLC: A Diagnostic Outcomes and Cost Analysis: Topic: EGFR Biomarkers

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Review of Health State Utility Values Used in UK Nice Appraisals in Advanced NSCLC

2016 Value in Health
Show All
- Source
- Cite
- Save
Citations (4)